Table 4

Multivariate linear regression models exploring the independent association between SF-36 PCS (dependent variable) and other clinical and demographic variables

SF-36 PCS (model 1)SF-36 PCS (model 2)SF-36 PCS (model 3)SF-36 PCS (model 4)
B (95% CI)βp ValueB (95% CI)βp ValueB (95% CI)βp ValueB (95% CI)βp Value
BASFI−1.739 (−2.210 to −1.268)−0.456<0.001−1.652 (−2.126 to −1.179)−0.433<0.001
BASMI−0.715 (−1.295 to −0.136)−0.1530.016−0.945 (−1.502 to −0.388)−0.2020.001
ASDAS−2.046 (−3.051 to −1.041)−0.240<0.001−3.487 (−4.497 to −2.476)−0.408<0.001
BASDAI−1.309 (−1.877 to −0.741)−0.275<0.001−2.209 (−2.755 to −1.663)−0.464<0.001
Disease duration0.271 (−0.601 to 1.143)0.0370.540−0.019 (−0.878 to 0.840)−0.0030.9651.049 (0.083 to 2.015)0.1420.0330.591 (−0.348 to 1.530)0.0800.216
Age−0.092 (−0.183 to −0.001)−0.1260.049−0.085 (−0.175 to 0.004)−0.1170.062−0.148 (−0.247 to −0.049)−0.2030.004−0.127 (−0.222 to −0.031)−0.1730.010
BMI0.063 (−0.141 to 0.267)0.0350.5450.082 (−0.119 to 0.283)0.0460.424−0.101 (−0.320 to 0.119)−0.0560.367−0.049 (−0.262 to 0.163)−0.0270.649
Gender (male)2.572 (0.679 to 4.464)0.1460.0081.926 (0.054 to 3.799)0.1100.0443.451 (1.357 to 5.546)0.1960.0012.415 (0.381 to 4.448)0.1370.020
R2=0.41R2=0.42R2=0.27R2=0.32
adjR2=0.39adjR2=0.40adjR2=0.25adjR2=0.30
  • p Values <0.05 are highlighted in bold.

  • adjR2, adjusted R2, a better estimate of the population value of R2; ASDAS, Ankylosing Spondylitis Disease Activity Score; B, regression coefficient; β, standardised coefficient; BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; BASFI, Bath Ankylosing Spondylitis Functional Index; BMI, Body Mass Index; R2, an estimate of the proportion of variance in the dependent variable accounted for by the regression; SF-36 PCS, SF-36 Physical Component Summary Score; SF-36 MCS, SF-36 Mental Component Summary Score.